Search - tctmd.com

Displaying 721 - 740 of 1588

Sort: Relevancy | Date

News Conference News TCT 2018

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

TCT Daily Staff

September 27, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

‘Telestenting’ an Early-Days but Enticing Idea for PCI’s Future

Lucy Hicks

September 27, 2018

News Conference News TCT 2018

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Shelley Wood

September 26, 2018

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Presenter: James B. Hermiller Jr, Hiroki Shiomi

September 25, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Todd Neale

September 25, 2018

Presentation TCT 2018

OAC ALONE: Summary and Clinical Implications

Presenter: John A. Bittl, David Erlinge, Takashi Kubo, Yukiko Nakano

September 24, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

Presentation TCT 2018

LRP: Summary and Clinical Implications

Presenter: John A. Bittl, David Erlinge, Takashi Kubo, Ron Waksman

September 24, 2018

Presentation TCT 2018

Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Chandan Devireddy

September 24, 2018

Presentation TCT 2018

ULTIMATE: Summary and Clinical Implications

Presenter: John A. Bittl, David Erlinge, Takashi Kubo, Junjie Zhang

September 24, 2018

Presentation TCT 2018

Alcohol-Mediated Renal Denervation Current Status and US Pivotal Trial Plans

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh

September 24, 2018

News Conference News TCT 2018

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Lucy Hicks

September 24, 2018

Presentation TCT 2018

Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, David E. Kandzari

September 24, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

Advertisement

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

‘Telestenting’ an Early-Days but Enticing Idea for PCI’s Future

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

OAC ALONE: Summary and Clinical Implications

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

LRP: Summary and Clinical Implications

Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now?

ULTIMATE: Summary and Clinical Implications

Alcohol-Mediated Renal Denervation Current Status and US Pivotal Trial Plans

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content